Parkinson's disease (PD): peripheral neuropathy
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Parkinson's disease (PD): peripheral neuropathy. Severity of PD, Levodopa exposure: levodopa-induced neuropathy. Fully referenced neurology checklist.
Risk factors
- Severity of PD
- Levodopa exposure: levodopa-induced neuropathy
- Vitamin B12 deficiency
- Hyperhomocysteinaemia
- PD degeneration
Genetic disorders manifesting with PD and PN
Locked: subscribe to see this section.
PD neuropathy types
Locked: subscribe to see this section.
References
- Merola A, Rosso M, Romagnolo A, et al. Peripheral neuropathy as marker of severe Parkinson's disease phenotype. Mov Disord 2017; 32:1256-1258.
- Ceravolo R, Cossu G, Bandettini di Poggio M, et al. Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. Mov Disord 2013; 28:1391-1397.
- Romagnolo A, Merola A, Artusi CA, Rizzone MG, Zibetti M, Lopiano L. Levodopa-induced neuropathy: a systematic review. Mov Disord Clin Pract 2018; 6:96-103.
- Rajabally YA, Martey J. Neuropathy in Parkinson disease: prevalence and determinants. Neurology 2011; 77:1947-1950.
- Zis P, Grünewald RA, Chaudhuri RK, Hadjivassiliou M. Peripheral neuropathy in idiopathic Parkinson's disease: A systematic review. J Neurol Sci 2017; 378:204-209.
- And 8 more. Subscribe to see the full list
Related checklists
- Parkinson’s disease (PD): hallucinations
- Parkinson’s disease (PD): psychiatric features
- Parkinson’s disease (PD): autonomic features
- Parkinson's disease (PD): hyposmia
- Parkinson's disease (PD): ophthalmic features
- Parkinson's disease (PD): muscular features
- Parkinson's disease (PD): systemic features
- Parkinson’s disease (PD): pain
- Parkinson’s disease (PD): cognitive features
- Parkinson’s disease (PD): sleep-related disorders